HIV drug showdown: could one treatment help shrink the hidden virus?
NCT ID NCT05584397
First seen Apr 30, 2026 · Last updated Apr 30, 2026
Summary
This study looks at 40 people with HIV to see if different types of HIV medications affect the hidden virus (the HIV reservoir) and immune system differently. Researchers want to know if a drug called tenofovir might cause more immune activation and keep the virus hiding longer. The goal is to find ways to improve HIV treatment and reduce long-term inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Washington Positive Research and the Gastroenterology Clinic at Harborview Medical Center
Seattle, Washington, 98104, United States
Conditions
Explore the condition pages connected to this study.